Avery Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $8.47M (Form D filed Sep 21, 2026). SEC Form D 0001708135-26-000003 (Sep 21, 2026)
  Evidence (1 event)

  • Sep 21, 2026 · SEC Form D 0001708135-26-000003
    Name of Issuer: Avery Therapeutics, Inc.; CIK: 1708135; Address: Tucson, AZ; Submission type: D; Filing date: 2026-09-21; Industry Group: Biotechnology; Date of First Sale: 2026-08-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 15400000; Total Amount Sold: 8468859; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals